Nutrien (NYSE:NTR) Price Target Raised to $70.00

Nutrien (NYSE:NTR) had its target price upped by equities research analysts at Barclays from $64.00 to $70.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s target price points to a potential downside of 0.69% from the company’s current price.

NTR has been the topic of a number of other research reports. Morgan Stanley raised shares of Nutrien from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $70.00 to $77.00 in a report on Wednesday, January 14th. Weiss Ratings restated a “hold (c)” rating on shares of Nutrien in a report on Monday, December 29th. Royal Bank Of Canada lifted their price objective on Nutrien from $70.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, January 20th. Wall Street Zen raised Nutrien from a “hold” rating to a “buy” rating in a report on Saturday, January 31st. Finally, Mizuho lifted their price target on Nutrien from $65.00 to $68.00 and gave the stock a “neutral” rating in a research note on Friday, January 16th. Two analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $66.69.

Nutrien Stock Performance

Nutrien stock traded up $0.63 during midday trading on Wednesday, hitting $70.49. 382,519 shares of the company’s stock were exchanged, compared to its average volume of 2,918,399. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.89 and a current ratio of 1.41. The stock has a market cap of $33.94 billion, a price-to-earnings ratio of 19.00 and a beta of 0.73. Nutrien has a 12-month low of $45.78 and a 12-month high of $73.55. The firm’s 50 day simple moving average is $65.62 and its 200 day simple moving average is $60.42.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Montag A & Associates Inc. boosted its stake in Nutrien by 310.7% during the 4th quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock valued at $26,000 after purchasing an additional 320 shares during the period. Root Financial Partners LLC acquired a new stake in shares of Nutrien in the 3rd quarter worth approximately $37,000. Sfam LLC bought a new position in Nutrien during the 4th quarter valued at $37,000. Huntington National Bank grew its holdings in Nutrien by 72.6% during the second quarter. Huntington National Bank now owns 656 shares of the company’s stock worth $38,000 after acquiring an additional 276 shares during the period. Finally, Eastern Bank raised its holdings in shares of Nutrien by 133.0% in the 4th quarter. Eastern Bank now owns 699 shares of the company’s stock worth $43,000 after purchasing an additional 399 shares in the last quarter. 63.10% of the stock is owned by hedge funds and other institutional investors.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.